{"title":"新型双吲哚生物碱 iheyamine A 的合成、结构修饰和生物活性","authors":"","doi":"10.1016/j.bioorg.2024.107757","DOIUrl":null,"url":null,"abstract":"<div><p>Diseases caused by plant viruses and pathogens pose a serious threat to crop yield and quality. Traditional pesticides have gradually developed drug resistance and brought certain environmental safety issues during long-term overuse. There is an urgent need to discover new candidate compounds to address these issues. In this study, we achieved the efficient synthesis of iheyamine A and its derivatives, and discovered their excellent antiviral activities against tobacco mosaic virus (TMV). Most compounds displayed higher antiviral activities against TMV than commercial ribavirin at 500 μg/mL, with compounds <strong>3a</strong> (Inactive effect IC<sub>50</sub>: 162 µg/mL), <strong>3d</strong> (Inactive effect IC<sub>50</sub>: 249 µg/mL), <strong>6p</strong> (Inactive effect IC<sub>50</sub>: 254 µg/mL), and <strong>7a</strong> (Inactive effect IC<sub>50</sub>: 234 µg/mL) exhibiting better antiviral activities than ningnanmycin at 500 μg/mL (Inactive effect IC<sub>50</sub>: 269 µg/mL). Meanwhile, the structure–activity relationships of this type of compounds were systematically studied. We chose <strong>3a</strong> for further antiviral mechanism research and found that it can directly act on viral coat protein (CP). The interaction of <strong>3a</strong> and CP was further verified via molecular docking. These compounds also showed broad-spectrum fungicidal activities against 8 plant pathogenic fungi, especially for <em>P. piricola</em>. This study provides a reference for the role of iheyamine alkaloids in combating plant pathogenic diseases.</p></div>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":null,"pages":null},"PeriodicalIF":4.5000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Synthesis, structural modification, and biological activity of a novel bisindole alkaloid iheyamine A\",\"authors\":\"\",\"doi\":\"10.1016/j.bioorg.2024.107757\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Diseases caused by plant viruses and pathogens pose a serious threat to crop yield and quality. Traditional pesticides have gradually developed drug resistance and brought certain environmental safety issues during long-term overuse. There is an urgent need to discover new candidate compounds to address these issues. In this study, we achieved the efficient synthesis of iheyamine A and its derivatives, and discovered their excellent antiviral activities against tobacco mosaic virus (TMV). Most compounds displayed higher antiviral activities against TMV than commercial ribavirin at 500 μg/mL, with compounds <strong>3a</strong> (Inactive effect IC<sub>50</sub>: 162 µg/mL), <strong>3d</strong> (Inactive effect IC<sub>50</sub>: 249 µg/mL), <strong>6p</strong> (Inactive effect IC<sub>50</sub>: 254 µg/mL), and <strong>7a</strong> (Inactive effect IC<sub>50</sub>: 234 µg/mL) exhibiting better antiviral activities than ningnanmycin at 500 μg/mL (Inactive effect IC<sub>50</sub>: 269 µg/mL). Meanwhile, the structure–activity relationships of this type of compounds were systematically studied. We chose <strong>3a</strong> for further antiviral mechanism research and found that it can directly act on viral coat protein (CP). The interaction of <strong>3a</strong> and CP was further verified via molecular docking. These compounds also showed broad-spectrum fungicidal activities against 8 plant pathogenic fungi, especially for <em>P. piricola</em>. This study provides a reference for the role of iheyamine alkaloids in combating plant pathogenic diseases.</p></div>\",\"PeriodicalId\":257,\"journal\":{\"name\":\"Bioorganic Chemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-08-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic Chemistry\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S004520682400662X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S004520682400662X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
植物病毒和病原体引起的病害严重威胁着作物的产量和质量。传统农药在长期过度使用过程中逐渐产生了抗药性,并带来了一定的环境安全问题。目前迫切需要发现新的候选化合物来解决这些问题。在本研究中,我们实现了 iheyamine A 及其衍生物的高效合成,并发现了它们对烟草花叶病毒(TMV)的优异抗病毒活性。大多数化合物对烟草花叶病毒的抗病毒活性高于500微克/毫升的利巴韦林,其中化合物3a(非活性效应IC50:162微克/毫升)、3d(非活性效应IC50:249微克/毫升)、6p(非活性效应IC50:254微克/毫升)和7a(非活性效应IC50:234微克/毫升)的抗病毒活性优于500微克/毫升的宁南霉素(非活性效应IC50:269微克/毫升)。同时,我们还系统地研究了这类化合物的结构-活性关系。我们选择了 3a 作进一步的抗病毒机制研究,发现它能直接作用于病毒衣壳蛋白(CP)。通过分子对接进一步验证了 3a 与 CP 的相互作用。这些化合物还对 8 种植物病原真菌表现出广谱杀菌活性,尤其是对 P. piricola。这项研究为九里香生物碱在防治植物病原性疾病中的作用提供了参考。
Synthesis, structural modification, and biological activity of a novel bisindole alkaloid iheyamine A
Diseases caused by plant viruses and pathogens pose a serious threat to crop yield and quality. Traditional pesticides have gradually developed drug resistance and brought certain environmental safety issues during long-term overuse. There is an urgent need to discover new candidate compounds to address these issues. In this study, we achieved the efficient synthesis of iheyamine A and its derivatives, and discovered their excellent antiviral activities against tobacco mosaic virus (TMV). Most compounds displayed higher antiviral activities against TMV than commercial ribavirin at 500 μg/mL, with compounds 3a (Inactive effect IC50: 162 µg/mL), 3d (Inactive effect IC50: 249 µg/mL), 6p (Inactive effect IC50: 254 µg/mL), and 7a (Inactive effect IC50: 234 µg/mL) exhibiting better antiviral activities than ningnanmycin at 500 μg/mL (Inactive effect IC50: 269 µg/mL). Meanwhile, the structure–activity relationships of this type of compounds were systematically studied. We chose 3a for further antiviral mechanism research and found that it can directly act on viral coat protein (CP). The interaction of 3a and CP was further verified via molecular docking. These compounds also showed broad-spectrum fungicidal activities against 8 plant pathogenic fungi, especially for P. piricola. This study provides a reference for the role of iheyamine alkaloids in combating plant pathogenic diseases.
期刊介绍:
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.
For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.
The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.